InvestSMART

Rhythm Biosciences Limited (ASX:RHY)

ALERT: Price-sensitive ASX Announcement for RHY
Current share price for RHY : $0.080 -0.115 (-58.97%)+
Announcement
Release
14 Apr 2026 4:53PM
Price at Release
$0.195
Full Release
download
Summary
Rhythm Biosciences Limited responded to a query from the ASX concerning discrepancies and issues related to their Underwriting Agreement executed on 24-25 February 2026. The ASX sought clarifications on the execution date and detailed termination events. RHY confirmed that the termination provisions in the Prospectus dated 30 March 2026 accurately reflect the executed Underwriting Agreement, superseding earlier announcements. The company admitted to administrative errors in previous disclosures and has since reviewed its procedures to ensure compliance with ASX Listing Rules and its Continuous Disclosure Policy. RHY affirmed that the Underwriting Agreement remains in full effect.
Key Points
  • The Underwriting Agreement was executed overnight on 24-25 February 2026.
  • ASX raised queries regarding the Underwriting Agreement, including the execution date and termination events.
  • Termination events were disclosed in a market-sensitive announcement on 25 February 2026.
  • The termination provisions in the Prospectus dated 30 March 2026 supersede those in the 25 February Announcement.
  • RHY's Continuous Disclosure Policy was referenced in ensuring accurate information disclosure.
  • The company confirmed that the Underwriting Agreement remains in full effect and is compliant with ASX Listing Rules.
  • RHY acknowledged an administrative oversight in its Appendix 3B released on 2 April 2026.
  • The company has reviewed its processes to avoid future inaccuracies in announcements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.